Apraxia Global Market Report 2025

The apraxia market size has grown strongly in recent years. It will grow from $2.33 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to increasing awareness of apraxia in both children and adults, a rising prevalence of neurological disorders, improved access to healthcare and therapies, greater funding for neurological research, and the expansion of speech-language pathology programs.

The apraxia market size is expected to see strong growth in the next few years. It will grow to $3.22 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period is expected to be driven by the increasing adoption of advanced diagnostic tools, the expansion of teletherapy services, rising government initiatives for early diagnosis, a growing focus on personalized therapy solutions, and broader insurance coverage for therapies. Key trends during this period include AI-driven speech therapy apps, wearable neurostimulation devices, advancements in diagnostic imaging, personalized rehabilitation programs, teletherapy platforms, brain-computer interfaces, and the development of novel pharmacological treatments.

The increasing prevalence of neurological disorders is expected to drive the growth of the apraxia market in the coming years. Neurological disorders affect the brain, spinal cord, and nerves, leading to various impairments such as cognitive, motor, sensory, and behavioral dysfunctions. Several factors, including an aging population, increased awareness, and changing lifestyles, contribute to the rising incidence of these conditions. Apraxia serves as a crucial indicator of brain function impairment, particularly in regions responsible for planning and coordinating movements, making it essential for diagnosing and treating neurological disorders. For example, in April 2022, the European Brain Council, a Belgium-based non-profit organization, reported that more than 600 neurological diseases and nearly 300 psychiatric conditions impact millions worldwide, including 65 million individuals with epilepsy. In Europe alone, 10.5 million people are living with dementia, with projections estimating an increase to 18.7 million by 2050. As a result, the growing number of neurological disorders is fueling the expansion of the apraxia market.

Companies operating in the apraxia market are engaging in strategic collaborations to enhance research efforts, broaden treatment options, and improve patient care. In July 2024, Trios Health, a US-based healthcare company, partnered with Washington State University’s Department of Speech and Hearing Sciences to introduce a specialized program called “Camp I Can Say It!”. This initiative is designed to assist children between the ages of 5 and 7 who experience childhood apraxia of speech (CAS) and other severe speech disorders. The camp provides bilingual speech therapy for both English- and Spanish-speaking children and integrates early literacy development, offering a well-rounded approach to enhancing communication and academic skills.

In July 2022, ArchiMed SAS, a France-based investment company specializing in healthcare industries, acquired Natus Medical Incorporated for $1.1 billion. This acquisition aims to strengthen ArchiMed SAS's position in the neurodiagnostic device market while leveraging Natus’ expertise and product offerings to drive innovation. Natus Medical Incorporated, a US-based company, specializes in medical devices and services focused on newborn care, neurology, sleep disorders, hearing, and balance assessment. This acquisition is expected to foster growth and advancement in the neurodiagnostic sector.

Major players in the apraxia market are Creative Expression Therapy (CET), North Shore Pediatric Therapy, Meredith Brand Therapy LLC, Chicago Speech Therapy, Expressable, Lingraphica, Instrumental Speech Language Pathology (Instrumental SLP), Voz Speech Therapy, Kaufman Children's Center, Chatterboxes Speech-Language & Occupational Therapy, TalkTools, Speech Therapy Centres of Canada, Speak Live Play, Northeast Hearing & Speech, The Center for Speech, Language, Occupational Therapy and Applied Behavior Analysis, Speech Bee, Dynamic Speech Therapy, A Mile High Speech Therapy, Tactus Therapy Solutions, and Con Moto Speech Services.

North America was the largest region in the apraxia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in apraxia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the apraxia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Apraxia is a neurological disorder that impairs purposeful movements despite normal muscle strength, coordination, and comprehension. It is caused by brain damage, often affecting motor planning areas such as the parietal or frontal lobes. Individuals with apraxia may have difficulty performing tasks such as waving, tying shoelaces, or speaking.

The primary types of apraxia include ideomotor apraxia, ideational or conceptual apraxia, buccofacial or orofacial apraxia, constructional apraxia, gait apraxia, limb-kinetic apraxia, oculomotor apraxia, and apraxia of speech. Ideomotor apraxia is marked by difficulty executing voluntary movements or actions, even when the individual understands the task and has the physical capability to perform it. Treatment options for apraxia include speech therapy, occupational therapy, and physical therapy. Diagnosis typically involves assessments for upper limb apraxia, magnetic resonance imaging (MRI), and other tests.

The apraxia market research report is one of a series of new reports that provides apraxia market statistics, including the apraxia industry's global market size, regional shares, competitors with a apraxia market share, detailed apraxia market segments, market trends and opportunities, and any further data you may need to thrive in the apraxia industry. This apraxia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The apraxia market includes revenues earned by providing services such as speech therapy, diagnostic assessments, and therapeutic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.